Abstract | BACKGROUND: Prematurity may be a risk factor for Haemophilus influenzae type b vaccine failure. This article evaluates the Haemophilus influenzae type b immunogenicity of a hexavalent diphtheria- tetanus-acellular pertussis- hepatitis B-inactivated poliovirus/Haemophilus influenzae type b vaccine in preterm infants (< 37 weeks' gestation). METHODS: This was an open-label, parallel group study. Preterm (N = 94) and term infants (N = 92) received 3 doses of a diphtheria- tetanus-acellular pertussis- hepatitis B-inactivated poliovirus/Haemophilus influenzae type b vaccine at 2, 4, and 6 months with a booster dose at 18 to 20 months. Antipolyribosyl ribitol phosphate antibody concentrations were determined in serum samples taken before and 1 month after primary and booster vaccination. RESULTS: Postprimary seroprotection rates (antipolyribosyl ribitol phosphate > or = 0.15 microg/mL) were lower in preterm than in term infants (92.5% vs 97.8%), with antipolyribosyl ribitol phosphate geometric mean concentrations of 2.241 vs 4.247 microg/mL. A progressive reduction in immune response to the Haemophilus influenzae type b antigen was observed with decreasing length of gestation and decreasing birth weight when cutoff > or = 1 microg/mL was considered. Prebooster seroprotection rates and antipolyribosyl ribitol phosphate geometric mean concentrations were low in both groups (antipolyribosyl ribitol phosphate > or = 1.0 microg/mL in 10.7% of preterm and 28.4% of term infants). A vigorous response to booster vaccination was seen in both groups, with no differences in postbooster seroprotection rates or antipolyribosyl ribitol phosphate geometric mean concentrations between the 2 groups (antipolyribosyl ribitol phosphate > or = 1.0 microg/mL in 100% of preterm and 98.5% of term infants). CONCLUSIONS: Primary vaccination with a hexavalent diphtheria- tetanus-acellular pertussis- hepatitis B-inactivated poliovirus/Haemophilus influenzae type b vaccine at 2, 4, and 6 months with a booster dose at 18 to 20 months elicits a satisfactory antipolyribosyl ribitol phosphate response in preterm infants compared with term controls. Immunologic response decreased with decreased gestational age and birth weight.
|
Authors | Felix Omeñaca, José Garcia-Sicilia, Pilar García-Corbeira, Reyes Boceta, Victorio Torres |
Journal | Pediatrics
(Pediatrics)
Vol. 119
Issue 1
Pg. e179-85
(Jan 2007)
ISSN: 1098-4275 [Electronic] United States |
PMID | 17145903
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DTPa-HBV-IPV combined vaccine
- Diphtheria-Tetanus-Pertussis Vaccine
- Haemophilus Vaccines
- Haemophilus influenzae type b polysaccharide vaccine
- Hepatitis B Vaccines
- Poliovirus Vaccine, Inactivated
- Polysaccharides
- Polysaccharides, Bacterial
- Vaccines, Combined
- polyribitol phosphate
|
Topics |
- Antibody Formation
- Bacterial Capsules
- Birth Weight
- Diphtheria-Tetanus-Pertussis Vaccine
- Gestational Age
- Haemophilus Vaccines
(immunology)
- Hepatitis B Vaccines
- Humans
- Immunization Schedule
- Immunization, Secondary
- Infant
- Infant, Newborn
- Infant, Premature
(immunology)
- Poliovirus Vaccine, Inactivated
- Polysaccharides
(immunology)
- Polysaccharides, Bacterial
(immunology)
- Vaccines, Combined
(immunology)
|